MedTrace Logo

Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness

NCT00793741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2018-01-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether islet transplantation alters brain glucose concentrations in patients with type 1 diabetes, recurrent hypoglycemia, and hypoglycemia unawareness when compared to that measured prior to transplant in the same subjects.

Conditions

Interventions

DRUG

somatostatin

Somatostatin may be used to suppress endogenous insulin secretion

Sponsors & Collaborators

Principal Investigators

  • Elizabeth R Seaquist, MD · University of Minnesota

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00793741 on ClinicalTrials.gov